ATA92196A - Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität - Google Patents

Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität

Info

Publication number
ATA92196A
ATA92196A AT0092196A AT92196A ATA92196A AT A92196 A ATA92196 A AT A92196A AT 0092196 A AT0092196 A AT 0092196A AT 92196 A AT92196 A AT 92196A AT A92196 A ATA92196 A AT A92196A
Authority
AT
Austria
Prior art keywords
activity
pharmaceutical preparation
factor viii
procoagulation
vwf binding
Prior art date
Application number
AT0092196A
Other languages
English (en)
Other versions
AT403438B (de
Inventor
Jan Voorberg
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT0092196A priority Critical patent/AT403438B/de
Priority to CA002205824A priority patent/CA2205824A1/en
Priority to EP97890095A priority patent/EP0808901A3/de
Priority to JP9134976A priority patent/JPH1057060A/ja
Publication of ATA92196A publication Critical patent/ATA92196A/de
Application granted granted Critical
Publication of AT403438B publication Critical patent/AT403438B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0092196A 1996-05-24 1996-05-24 Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität AT403438B (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AT0092196A AT403438B (de) 1996-05-24 1996-05-24 Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität
CA002205824A CA2205824A1 (en) 1996-05-24 1997-05-22 Pharmaceutical preparation with factor viii procoagulant activity and vwf binding activity
EP97890095A EP0808901A3 (de) 1996-05-24 1997-05-23 Pharmazeutische Präparation mit Faktor VIII-Prokoagulations-aktivität und vWF-Bindungs-aktivität
JP9134976A JPH1057060A (ja) 1996-05-24 1997-05-26 第ＶＩＩＩ因子凝固活性およびｖＷＦ結合活性を示す医薬製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0092196A AT403438B (de) 1996-05-24 1996-05-24 Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität

Publications (2)

Publication Number Publication Date
ATA92196A true ATA92196A (de) 1997-07-15
AT403438B AT403438B (de) 1998-02-25

Family

ID=3502907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0092196A AT403438B (de) 1996-05-24 1996-05-24 Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität

Country Status (4)

Country Link
EP (1) EP0808901A3 (de)
JP (1) JPH1057060A (de)
AT (1) AT403438B (de)
CA (1) CA2205824A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376463B1 (en) 1992-04-07 2002-04-23 Emory University Modified factor VIII
DK1129186T4 (da) 1998-11-10 2017-02-06 Stichting Sanquin Bloedvoorziening Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
EP1183354A2 (de) * 1999-05-24 2002-03-06 The American National Red Cross Verfahren, die dem abbau von faktor-viii entgegenwirken, und dazugehörigen zusammensetzungen
JP2005518181A (ja) * 2001-01-12 2005-06-23 ジ・アメリカン・ナショナル・レッド・クロス 第ｖｉｉｉ因子のヘパラン硫酸プロテオグリカン仲介性クリアランスを低下させるための方法および組成物
US7211559B2 (en) 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods
ES2821832T3 (es) 2004-11-12 2021-04-27 Bayer Healthcare Llc Modificación de FVIII dirigida al sitio

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606925B2 (en) * 1987-01-30 1991-02-21 Biogen, Inc. A method for producing factor viii in high yield
EP0690126B1 (de) * 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen
US5663060A (en) * 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
AU1382595A (en) * 1994-01-07 1995-08-01 Novo Nordisk A/S Factor viii derivatives

Also Published As

Publication number Publication date
CA2205824A1 (en) 1997-11-24
EP0808901A3 (de) 1999-05-06
AT403438B (de) 1998-02-25
JPH1057060A (ja) 1998-03-03
EP0808901A2 (de) 1997-11-26

Similar Documents

Publication Publication Date Title
DE69709885D1 (de) Speichersystem und einrichtung
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
DE69739677D1 (de) OB Rezeptor-Variante und Liganden
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
FI946005L (fi) Glysiinireseptoriantagonisteja ja niiden käyttö
DE69825910T8 (de) Gekräuselte Multikomponentenfilamente und daraus hergestellte Spinnvliese
DE69801976D1 (de) Zusammensetzung und Gegenstand mit verbessertem Druckverformungsrest
DE69824175D1 (de) Nachfüllbarer stent und verabreichungssystem
FI955311A7 (fi) Farmaseuttinen koostumuspohja
NZ329429A (en) Vitronectin receptor antagonists comprising fibrinogen receptor antagonists and medicaments thereof
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
DE4294862T1 (de) Pharmazeutische Komposition
ATA92196A (de) Pharmazeutische präparation mit faktor viii prokoagulationsaktivität und vwf-bindungsaktivität
ATE208364T1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
DE69312319D1 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
FI931682A7 (fi) Tackykiniinireseptoriantagonistit, isokinolonit ja niiden valmistus
ID18698A (id) Komposisi farmasi
DE68927854D1 (de) Insulinomimetrische eigenschaften und insulin-rezeptor-bindestellen-peptide
DE69715247D1 (de) Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung
EE03618B1 (et) Bitsüklilised tahhükiniini antagonistid, nende valmistamine ja kasutamine ravimsegus
FI961364L (fi) Lääkeainekoostumus
GB9704800D0 (en) Improvement in post support
ZA981782B (en) The use of levobupivacaine in combination with other drugs

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee